'Those with MS should have access to any licensed treatments that would improve their condition, including cannabis based ones'

Dr Brian Sweeney joined George Hook on High Noon today.

Dr Brian Sweeney, Consultant Neurologist in Cork University Hospital, has called for Sativex, the cannabis-based drug licensed in Ireland for the treatment of spasticity in MS, to be made available to patients who need it.

He joined George Hook on High Noon today.

Despite Sativex being approved in July 2014 it is still not available as no commercial deal seems to have been struck between the European distributor of the drug, Allmiral, and the HSE.

Dr Sweeney says that people with MS should have access to any licensed treatments that would improve their condition.

“While there is a great focus on long-term treatments to prevent multiple sclerosis from getting worse, there is still a need for treatments for symptoms of MS, such as spasticity, pain, urinary dysfunction, tremor and sleep disturbance" says Dr Sweeney.

He thinks about 20-30% of his patients would benefit greatly from the drug.

You can listen to the full interview by clicking below.